- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07075159
- Original Trial
Hydrocolloid Dressings for Oculofacial Plastic and Reconstructive Wound Healing (HCD Wound Heal)
This study aims to explore the use of a hydrocolloid dressing (DuoDERM EXTRA THIN) as an alternative to the current standard of care. The dressing would be applied immediately after surgery and removed at a post-operative week 1 appointment. The dressing would eliminate the need for antibiotic ointment application and reduce the burden of post-operative care on the patient.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Kentucky
-
Lexington, Kentucky, United States, 40508
- University of Kentucky
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients >18 years of age
- follow-up at specified intervals (1 week/6 week/3 months) in an office setting
- can give informed consent
- no patients will be excluded on the basis of gender, ethnicity, or religious background
Exclusion Criteria:
- Patients <18 years of age or >100
- allergy to pectin, gelatin, and sodium carboxymethylcellulose
- adults with impaired consent capacity
- incarcerated individuals.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Wound Dressing
At the conclusion of the surgical procedure, patients will receive topical wound dressing to surgical sutured periocular wounds |
one time hydrocolloid dressing application
Other Names:
|
|
No Intervention: Antibiotic Ointment (Control)
At the conclusion of the surgical procedure, patients will receive topical antibiotic ophthalmic ointment to surgical sutured periocular wounds |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Participants With Wound Dehiscence
Time Frame: 3 months
|
YES/NO type question if wound dehiscence is present after removal of the patch |
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Participants Assessed Using the Patient and Observer Scar Assessment Scale
Time Frame: 3 months
|
Number of participants who completed the Patient and Observer Scar Assessment Scale following surgery. The assessment was performed at the 3 month postoperative visit to evaluate scar appearance filled out by both patient and provider. This survey is scaled from 0-10, with 0 being normal skin and 10 being very different skin. Lower scores are desired on this survey. |
3 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Janice Hernandez, MD, University of Kentucky
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 99942
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.